Compare2 funds · 1 pair
Picked · 2YTD
IXJvsBBCVersus · 5Y · 0.0% held in common4–2measures won
Close to theseFee · YTD
Best of the twoNov 6
  • Lowest cost$ a year on $10kIXJ 0.38%
  • Most incometrailing 12-month yieldBBC 1.52%
  • Best 5 yearsper yearIXJ +6.7%
  • Smallest drop · 1Yworst fall in the past yearIXJ −10.8%
Measures won4–2IXJ wins · of 6 · 5Y
$10,000 · 5Y$13,862IXJ · BBC $9,995
Lowest cost0.38%IXJ · $38 on $10k
Most income1.52%BBC · $152 on $10k
Smallest drop−10.8%IXJ · worst fall in 1Y
Held in common0.0%IXJ and BBC

IXJ vs BBC

5Y
IXJ
BBC
iShares Global Healthcare ETF · $4.6BVirtus Biotech Clinical Trials ETF · $34M
+14.0%3 years · per year$14,818 · $24,485+34.8%
+6.7%5 years · per year$13,862 · $9,995−0.0%
0.38%Expense ratio$38 · $65 on $10k · lower wins0.65%
1.28%12-mo yield$128 · $152 on $10k1.52%
−10.8%Worst dropSmaller wins−30.2%
16.3%VolatilityLower wins38.6%
4–2IXJ wins
$10,000 · 5 yearsOne scale
$10k startIXJ $13.9kBBC $10.0kOct 2021Nov 2026
Shared top holdingsIXJ · BBC

They share no top holdings, or holdings aren’t on file […]

Held in common0.0%
End-of-day Nov 6, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
@TheETFTracker·theetftracker.com

Both

5Y2 funds
#Trend
1AIXJiShares Global Healthcare ETFReadDesk0.38%1.28%+0.1%+17.0%+25.1%+14.0%+6.7%−10.8%$4.6B
2BBBCVirtus Biotech Clinical Trials ETFReadDesk0.65%1.52%+5.6%+11.6%+46.1%+34.8%0.0%−30.2%$34M
End-of-day Nov 6, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
@TheETFTracker·theetftracker.com

Cards for this view

IXJ vs BBC

5Y
iShares Global Healthcare
$13,862
Virtus Biotech Clinical Trials
$9,995
$5k$10kNov 2021Nov 2026$13,862$9,995$5k$10kNov 2021Nov 2026$13,862$9,995
MeasureIXJBBC
Fee0.38%0.65%
Cost on $10k a year$38$65
Yield1.28%1.52%
5 years, per year+6.7%−0.0%
3 years, per year+14.0%+34.8%
Worst drop · 1Y−10.8%−30.2%
Volatility · 1Y16.3%38.6%
4–2measures won
IXJ first
0.0%
holdings shared
Nov 6, 2026 · $10,000 five years ago, dividends reinvested
@TheETFTracker·theetftracker.com

SCHD vs VIG

YTD
SchwabSCHD
+31.4%
VIGVanguard
+12.1%
Jan 1Nov 6+31.4%+12.1%
+31.4%Year to date+12.1%
3.0%Yield1.5%
$120BAssets$109B
2–0SCHD wins
End-of-day Nov 6, 2026
@TheETFTracker·theetftracker.com

JEPQ vs JEPI

YTD
J.P. MorganJEPQ
+3.2%
JEPIJ.P. Morgan
+5.3%
Jan 1Nov 6+3.2%+5.3%
+3.2%Year to date+5.3%
12.8%Yield8.1%
$42.6BAssets$46.8B
1–1level
End-of-day Nov 6, 2026
@TheETFTracker·theetftracker.com

SPYM vs SPY

YTD
SPDRSPYM
+8.8%
SPYSPDR
+8.7%
Jan 1Nov 6+8.8%+8.7%
+8.8%Year to date+8.7%
1.1%Yield1.0%
$182BAssets$819B
2–0SPYM wins
End-of-day Nov 6, 2026
@TheETFTracker·theetftracker.com

Overlap: IXJ, BBC

Today
0.0%most shared, IXJ and BBC
IXJBBC
IXJ—0.0%
BBC0.0%—
End-of-day Nov 6, 2026 · share held in common · outlined: the pair in versus
@TheETFTracker·theetftracker.com

Income After Fees on $10,000

1Y
$90most kept, IXJ
IXJ$128 − $38 = $90
BBC$152 − $65 = $87
KeptFee
End-of-day Nov 6, 2026 · yield in dollars minus the fee
@TheETFTracker·theetftracker.com